ATLASTScan Therapeutics (TCRX) earnings date: Nov 11, 2026
TScan Therapeutics (TCRX) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026. Analysts expect EPS of -$0.18.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TCRX
| Last price | $0.18 (+4.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the TScan Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
TScan Therapeutics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on TScan Therapeutics. You can switch it off at any time.
Alert me before TCRX reportsFree to start. Creating an account takes under a minute.
Notify me when TScan Therapeutics reports
Track TCRX free Add TScan Therapeutics to a free ATLAS watchlist and see its next report date in one place.
TCRX earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.18 |
| Last report | Aug 12, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +2.4% |
| Average move around a report | ±3.6% (last 5) |
| Sector | Healthcare · Biotechnology |
TScan Therapeutics earnings history: last 5 reports
TScan Therapeutics last reported on Aug 12, 2026: EPS of -$0.23 against an estimate of -$0.20 (-15.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.20 | -$0.23 | -15.0% | Miss | -0.6% |
| May 6, 2026 | -$0.16 | -$0.22 | -37.5% | Miss | 0.0% |
| Apr 10, 2026 | -$0.16 | -$0.14 | +12.5% | Beat | -3.8% |
| Mar 4, 2026 | -$0.28 | -$0.18 | +35.7% | Beat | +9.2% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -4.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TCRX
See the fair value, the probability range and the earnings history of TScan Therapeutics on its ATLAS page.
TScan Therapeutics (TCRX) stock analysisPlans from €3.99 a month.
TScan Therapeutics earnings: frequently asked questions
When does TScan Therapeutics (TCRX) report earnings?
TScan Therapeutics is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TCRX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.18 per share (USD). Estimates can change before the report.
How often does TCRX beat earnings estimates?
Of its last 5 reports with a recorded result, TScan Therapeutics beat the EPS estimate 3 times; the average surprise was +2.4%. Past results do not predict the next one.
How much does TCRX move around earnings?
Over its last 5 reports the stock moved an average of 3.6% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did TScan Therapeutics beat earnings estimates last quarter?
TScan Therapeutics last reported on Aug 12, 2026: EPS of -$0.23 against an estimate of -$0.20 (-15.0% surprise), a miss.
How much does TCRX usually move in a day?
On a normal trading day the ATLAS model puts TCRX’s one-day range at about ±6.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer